Adding MS drug to t...
 

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes  

  RSS

johan
(@johan)
New Member
Joined: 1 year ago
Posts: 183
09/08/2019 4:46 pm  

"When treated with both teriflunomide and BKM-120, tumours shrank markedly on average and the mice survived significantly longer, compared to mock-treated mice or mice who received either treatment alone."

https://ecancer.org/news/16443-adding-ms-drug-to-targeted-cancer-therapy-may-improve-glioblastoma-outcomes.php


Daniel liked
Quote
Share: